Bohle Fluid Bed Sytsem BFS - Bohle Uni Cone BUC® - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Bohle Fluid Bed Sytsem BFS - Bohle Uni Cone BUC®

With the Bohle Uni Cone BUC ® process, L.B. Bohle can protect a new development method for precise coating of particles as a utility model right now. “This method works much more accurately and evenly than the conventional Wurster process”, says the CEO Lorenz Bohle.

The Wurster process is used, when small particle, so called pellets, must be coated. Biggest weaknesses are hardly calculable setting parameters and the spray nozzles in the bottom.

"We have developed two major changes that solve both problems of the Wurster process", says Bohle. A sloping floor and a conical tip in the center provide a uniform turbulence of the product. Simultaneously, the coating substance is spray to lateral nozzles. "We thus reach a hitherto possible coating uniformity, the losses are under one percent in a very complex process", said Bohle. Furthermore the Bohle Uni Cone BUC ® guarantees high yields in the final product due to absence of particle twinning effects. "The losses are under one percent in a very complex process."

The tangential nozzles have also enhanced quality advantages in handling.

By this reasons using the tangential BFS represents state of the art in pharmaceutical manufacturing for particle coating, granulation and drying.

Contact information:

Tobias Borgers
Head of Marketing
t.borgers@lbbohle.de
+49 2524 – 9323 150
+49 2524 – 93 23 399
www.lbbohle.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here